Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ·Healthcare·Biotechnology
$279.34
-0.77%
Mkt Cap $37.76B
Analyst Ratings
Buy
18
Hold
4
Sell
0
Price Target (67 analysts)
$460.50
Range $351.00 – $549.00
Implied Upside
+64.9%
Consensus $460.50 vs current $279.34